跳至主要内容
临床试验/NCT02501798
NCT02501798已完成4 期

The Effects of Long-acting Methylphenidate on Academic Activity and Related Constructs in Children With ADHD: A Randomised Placebo Controlled Trial

VU University of Amsterdam1 个研究点 分布在 1 个国家目标入组 61 人开始时间: 2013年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
61
试验地点
1
主要终点
Mathematical performance

研究概览

简要总结

This study aims at investigating the direct effects of methylphenidate on school performance of primary school children. Although behavioral effects of this frequently prescribed drug are thoroughly studied (and confirmed), the effects of methylphenidate on school performance are less clear. Recent overviews indicate that effects are mainly quantitative and subject-specific. To gain more insight in this issue, the current double blind placebo controlled crossover study investigates not only the effects of methylphenidate on school performance but also it's effect on related variables such as short term memory, motivation and behavior. 60 children with ADHD are included and tested twice (with medication and with placebo) at their primary school.

详细描述

Rationale: ADHD (attention deficit hyperactivity disorder) is a common childhood developmental disorder. Besides the behavioural symptoms of ADHD, many children with ADHD experience problems with academic activities. More specifically, these children show problems with math, spelling and reading. The most common treatment for ADHD is medical treatment with methylphenidate (MPH). This treatment is effective in the reduction of ADHD symptoms. However, it is unclear whether treatment with MPH can also improve academic activity. If MPH improves academic activity, it is of great interest to understand which variables influence or mediate this effect. The results from this study can give more insight in the working mechanisms and effectiveness of MPH in reducing the academic problems commonly observed in children with ADHD.

Objectives: The main objective of this study is to assess the impact of MPH on academic activity and to estimate the role of three putative mediators in this relation.

Study design and population: This study is a randomised, double-blind, placebo-controlled cross-over design with a patient group and a control group. Main study parameters/endpoints: The main study parameters are changes in academic activity (ability, effort and engagement). In addition, changes in putative mediators are assessed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
8 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • ADHD diagnosis (DSM-IV)
  • primary school education
  • sufficient knowledge of Dutch language

排除标准

  • neurological or psychiatric disorder other than ODD, CD, learning disorder, dyslexia, anxiety disorder
  • Healthy volunteers are accepted for the control group

研究组 & 干预措施

Drug: Methylphenidate

Experimental

Drug: Methylphenidate 7 days dosage as (prior to study) clinically titrated long acting Equasym (brand)

干预措施: Methylphenidate (Drug)

Drug: Placebo

Active Comparator

Drug: Placebo 7 days Empty green-yellow capsule

干预措施: Placebo (Drug)

结局指标

主要结局

Mathematical performance

时间窗: 3.5 years

A standardized task for mathematics is used. Productivity (% completed) and accuracy (%correct) will be calculated for analysis.

Reading performance

时间窗: 3.5 years

A standardized task for technical reading ability is used. Productivity (% completed) and accuracy (%correct) will be calculated for analysis.

Spelling performance

时间窗: 3.5 years

A standardized task for spelling is used. Productivity (% completed) and accuracy (%correct) will be calculated for analysis.

次要结局

  • Cognitive performance(3.5 years)
  • Academic motivation(3.5 years)
  • Classroom behavior(3.5 years)

研究者

发起方
VU University of Amsterdam
申办方类型
Other
责任方
Principal Investigator
主要研究者

Anne Fleur Kortekaas-Rijlaarsdam

A.F. Kortekaas-Rijlaarsdam

VU University of Amsterdam

研究点 (1)

Loading locations...

相似试验

进行中(未招募)
不适用
The Effects of Medical Treatment with Methylphenidate on Academic Activity and Related Skills in Children with ADHDAttention-deficit hyperactivity disorder (ADHD)
EUCTR2012-000492-17-NLAfdeling Klinische Neuropsychologie Vrije Universiteit Amsterdam
已完成
4 期
The effects of long-acting methylphenidate on academic activity and related constructs in children with ADHD: A randomised placebo controlled trialADHDhyperkynetic syndrome10037173
NL-OMON37537Vrije Universiteit100
Unknown
不适用
Adverse Effect of Prolonged Methylphenidate Treatment on Cardiac FunctionsAttention Deficit Disorder With HyperactivityAttention Deficit DisorderAttention Deficit Disorders With HyperactivityAttention Deficit Hyperactivity DisordersAttention Deficit Hyperactivity Disorder
NCT00372359Ornit Cohen50
进行中(未招募)
不适用
Effect of methylphenidate formulation on ADHD-patients' adherence to medical treatment. A comparison of Medikinet retard® (ER) once daily and Medikinet® (IR) twice daily in children and adolescents diagnosed with ADHD - Adherence to stimulant treatment in ADHD-patientsEffect of methylphenidate formulation on ADHD-patients adherence to treatmentMedDRA version: 9.1Level: LLTClassification code 10064104Term: ADHD
EUCTR2008-003285-26-DEniversität Mainz, Klinik und Poliklinik für Kinder- und Jugendpsychiatrie und -psychotherapie
终止
4 期
The Effect of Methylphenidate on Motor Learning in Stroke PatientsCerebrovascular Accident
NCT00396058University of Aarhus13